Name: Latest research reports of Abbott India Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Mid-range Performer

26135.0000 285.00 (1.10%)

NSE Sep 01, 2026 15:31 PM

Near 52W Low of ₹25150.00

Volume: 8,754

Abbott India Ltd.

13 May 2026

26135.00

1.10%

Abbott India (BUY): In line earnings; EBITDA Margin likely to sustain near its highs

Buy: Abbott India Ltd.

Target

BOB Capital Markets Ltd.

Sales/EBITDA/PAT reported -0.4%, -1.7%, -2.1% below our estimates. EBITDA Margin reported at 40 bps below our estimates

Abbott India Ltd. is trading below all available SMAs